<p>There have been several case reports of COVID-19 “BNT162b2” (Pfizer-BioNTech) and “mRNA-1273” (Moderna) vaccination associated small and medium vessel vasculitis described in the literature however none have had <sup>18</sup>F-FDG Positron Emission Tomography scans (PET/CT) performed for diagnosis. We report the case of a 57-year-old Caucasian male patient from Australia where <sup>18</sup>F-FDG PET/CT scanning facilitated early detection of a medium-vessel vasculitis following Moderna (mRNA-1273) COVID-19 vaccination. The diagnosis would otherwise have been difficult and allowed exclusion of alternative diagnoses and sparing of more invasive investigations such as muscle biopsy. Our case highlights the development of a medium vessel vasculitis following mRNA based COVID-19 vaccination and demonstrates the utility of <sup>18</sup>F-FDG PET/CT as an excellent non-invasive test for the detection of this serious rare and often difficult to diagnose condition.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Medium-vessel vasculitis following COVID-19 moderna (mRNA-1273) vaccination and the utility of PET-CT as a diagnostic tool: a case report

  • Martin H. Cherk,
  • Luigi Zolio,
  • Sadid Khan,
  • Sharmayne Brady

摘要

There have been several case reports of COVID-19 “BNT162b2” (Pfizer-BioNTech) and “mRNA-1273” (Moderna) vaccination associated small and medium vessel vasculitis described in the literature however none have had 18F-FDG Positron Emission Tomography scans (PET/CT) performed for diagnosis. We report the case of a 57-year-old Caucasian male patient from Australia where 18F-FDG PET/CT scanning facilitated early detection of a medium-vessel vasculitis following Moderna (mRNA-1273) COVID-19 vaccination. The diagnosis would otherwise have been difficult and allowed exclusion of alternative diagnoses and sparing of more invasive investigations such as muscle biopsy. Our case highlights the development of a medium vessel vasculitis following mRNA based COVID-19 vaccination and demonstrates the utility of 18F-FDG PET/CT as an excellent non-invasive test for the detection of this serious rare and often difficult to diagnose condition.